This is actually quite good for a subcutaneous peptide
Do semaglutide units work the same as insulin units
[46] After completing the SURPASS-2 trial (NCT03987919), the company announced in April 2022 that tirzepatide had successfully met its clinical endpoints in obese and overweight participants without diabetes
If you have a history of motion sickness or a sensitive stomach, you may experience a slightly longer adjustment period than others
Klinic's weight loss medications are generally appropriate for adults with a BMI in the obese range, or adults who are overweight and have at least one weight-related health condition such as high blood pressure, prediabetes, high cholesterol, or sleep apnea
46 The weight loss journey with these medications is a marathon, not a sprint